IONS
Ionis Pharmaceuticals, Inc.
Stock
$43.54−0.46 (−1.05%)Close Oct 2, 2026
- Revenue, 2025
- $944M
- YoY, 2025
- +33.8%
- 5-year CAGR
- +5.3%
- 10-year CAGR
- +12.8%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $944M | +33.8% |
| 2024 | $705M | −10.5% |
| 2023 | $788M | +34.1% |
| 2022 | $587M | −27.5% |
| 2021 | $810M | +11.1% |
| 2020 | $729M | −35.0% |
| 2019 | $1.1B | +87.2% |
| 2018 | $600M | +18.1% |
| 2017 | $508M | +46.5% |
| 2016 | $347M | +22.2% |
| 2015 | $284M | +32.5% |
| 2014 | $214M | +45.4% |
| 2013 | $147M | +44.3% |
| 2012 | $102M | +3.0% |
| 2011 | $99M | −8.7% |
| 2010 | $108M | −10.8% |
| 2009 | $122M | +13.4% |
| 2008 | $107M | — |